I'm sure you will read the stickies, but here is the rundown (from my perspective) from today's CC in a nutshell:
1. 2 months ago bought this shell - absolutely NO ENTANGLEMENTS OR AFFILIATIONS WITH ANY INDIVIDUAL FROM FORMER COMPANY
2. Clean reporting, planning on going to bigger boards as opportunity and stock permits.
3. 1 billion shares total. CEO personally owns most of them. Float is 92 million, but out of that float the majority of shares are actual certificates being held by people who are very unlikely to sell. They can if they wish, but most unlikely. The remainder of that float electronically traded is 12 million.
4. CEO has started successful pharm companies before. Granutec (sp?) in 1985 went from 3 employees to 242 employees & $1m sales to over $60m sales before being bought out around 1991, I think.
5. Just purchased new building & acreage for making Aquaprin which will pass stringent guidelines. Have room for expansion (and plans for it already).
6. Product combines aspirin in a tasty & water soluble form which will get entire aspirin content into bloodstream without going into digestion,which prohibits 40% of product through elimination. Other products are also developed for emergency applications ideally for stroke & heart attack victims. PRODUCT IS FDA APPROVED FOR OTC!
7. All future funding until product hits shelves will come from reserved stocks, which CANNOT be traded.
8. Product timeline to hit shelves is 14 months, normally would take up to 3 years, but past years of effort will expedite entire process.
9. Patent is current and continually updated with each improvement and new product made. INdependent auditor appraised patent for Aquaprin alone at $32m - a conservative figure simply to prove value of reserved shares in order to fund the process.
10. CEO is honest, forthright and genuine and has 3 decades of sterling reputation, contacts and other pharm companies are DEFINITELY AWARE OF HIS POTENTIAL AND PRODUCT.
IMO, float - even at 92 million - is so small, the only reason this company even went public was to have reserved shares for future funding. These shares available to the general public will be so rare, they will be very valuable.
This may jump and hop for a while and may not turn out to be a good stock to flip, but has enormous upside and is as close to a sure thing you will find here in PennyLand.
Just my perspective, trying to be unemotional, but pretty hard to be.
GLTA & Go PHAR
SO...WHO'S LAUGHING NOW?!?
